RP-HPLC comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-08-22. Where a claim depends on a specific study, the study is described rather than over-claimed.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
| Property | Value | Notes |
|---|---|---|
| Target receptor | GHRH receptor (GHRHR) | Expressed on pituitary somatotrophs |
| Primary action | Stimulates growth hormone release | Amplifies pulse size |
| Half-life, albumin-binding form | Several days as reported | Slow release from albumin complex |
| Half-life, unmodified analog | About 30 minutes in animal estimates | Cleared by proteases and filtration |
| Common analytical approach | LC-MS/MS for peptide, immunoassay for hormones | Methods answer different questions |
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
== Intellectual property == A2 Corporation licensed patents filed in the 1990s by the New Zealand Dairy Board and filed its own patents on genetic tests to determine what form of beta-casein cows produce in milk and concerning potential adverse health consequences of standard milk. By 2012 A2 Corporation had developed a worldwide suite of intellectual property, including trademarks, trade secrets, and patents covering products, the genetic test and methods to develop A1 protein-free producing herds, as well as methods to check the protein content and fatty acid content of milk, dietary supplements with A2 beta-casein, and even therapeutic uses of A1 protein-free products. The a2 Milk Company continues to develop a portfolio of intellectual property, including trademarks and patents. The a2 Milk Company also invests in targeted research and development associated with the benefits of the A2 protein. In September 2017, it was reported that the a2 Milk Company got approval to keep selling its products in China.
The Library of Congress, through both the librarian of Congress and the register of copyrights, is responsible for authorizing exceptions to Section 1201 of Title 17 of the United States Code as part of the Digital Millennium Copyright Act. This process is done every three years, with the register receiving proposals from the public and acting as an advisor to the librarian, who issues a ruling on what is exempt. After three years have passed, the ruling is no longer valid and a new ruling on exemptions must be made.
== Therapeutic relevance == Fundamental discoveries uncovering the biology of ferroptosis and translational studies showing the disease relevance of ferroptosis have motivated efforts to develop therapeutics that modulate ferroptosis. For example, Kojin Therapeutics and PTC Therapeutics are exploring ferroptosis modulation for treatment of cancer and Friedrich's ataxia. Ferroptosis has been implicated in a range of different diseases including cancer, ischemia/reperfusion injury (IRI), inflammation, neurodegeneration, and kidney injury.
Sources: en.wikipedia.org
=== Formulated intermediate moisture foods === Many types of food are specially formulated to achieve water activity in the IMF range. Food ingredients are mixed with salt and/or sugar, and additives (such as propylene glycol and potassium sorbate) and then subjected to processing methods such as cooking, extrusion or dehydration to result in an intermediate moisture final product. Examples of formulated IMF are confectioneries and pet food.
===== MeSH D08.811.520.650 – phosphorus-oxygen lyases (EC 4.6) ===== MeSH D08.811.520.650.200 – adenylate cyclase MeSH D08.811.520.650.200.040 – adenylate cyclase toxin MeSH D08.811.520.650.600 – guanylate cyclase MeSH D08.811.520.650.600.500 – receptors, guanylate cyclase-coupled MeSH D08.811.520.650.600.500.500 – receptors, atrial natriuretic factor MeSH D08.811.520.650.800 – phosphatidylinositol diacylglycerol-lyase
=== Young Investigator (YI) Post-Doctoral Programme === (RCB-YI award) has been initiated to nurture outstanding recent PhDs with innovative ideas and the drive to pursue novel discoveries under the mentorship of RCB faculty. RCB-YI award has been instituted for both Indian and Foreign nationals on the competitive basis with initial appointment for three years which is extendable on rigorous review for additional two years.
Sources: en.wikipedia.org
=== Scientific societies === William H. Stein was a member of several scientific societies, including the: National Academy of Sciences (elected to membership in 1960), American Academy of Arts and Sciences (elected to membership in 1960), American Society of Biological Chemists, Biochemical Society of London, American Chemical Society, American Association for the Advancement of Science, and Harvey Society of New York.
==== Case study ==== The Kennewick Man is a notable example of human remains caught in a struggle between scientific merit and cultural traditions. Since his discovery in 1996, his fate has been the topic of great controversy. As one of the oldest well-preserved ancient skeletons found in America, scientists are eager to conduct various testing on the remains. Native American groups, however, have been adamantly calling for his repatriation and reburial, as per their traditions.
Newsom was sworn in on January 7, 2019. Several recall attempts were launched against Newsom early in his tenure but failed to gain much traction. On February 21, 2020, a recall petition was introduced by Orrin Heatlie, a deputy sheriff in Yolo County. The petition mentioned Newsom's sanctuary state policy and said laws he endorsed favored "foreign nationals, in our country illegally"; said that California had high homelessness, high taxes, and low quality of life; and described other grievances. The California secretary of state approved it for circulation on June 10, 2020. Forcing the gubernatorial recall election required a total of 1,495,709 verified signatures. By August 2020, 55,000 signatures were submitted and verified by the secretary of state, and 890 new valid signatures were submitted by October 2020. The petition was initially given a signature deadline of November 17, 2020, but it was extended to March 17, 2021, after Judge James P. Arguelles ruled that petitioners could have more time because of the pandemic. Newsom's attendance at a party at The French Laundry in November 2020, despite his public health measures; voter anger over lockdowns, job losses, school and business closures; and a $31 billion fraud scandal at the state unemployment agency were credited for the recall's growing support.
Sources: en.wikipedia.org
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.
Typical endpoints include growth hormone pulse frequency and amplitude, together with insulin-like growth factor 1 concentration. Some protocols add body composition or metabolic markers. Interpretation depends on baseline hormonal status, which varies widely between individuals.
Most human data come from small, early-stage studies, and independent replication is limited. Short-term effects on growth hormone release are documented; longer-term outcomes are not well characterized. Open questions include changes in pituitary responsiveness after repeated exposure.
Chromatography reports how much material elutes as a single peak but does not confirm what that material is. Mass spectrometry supplies the molecular mass, which is characteristic of a given sequence and its modifications. Together the two methods support both a purity figure and an identity claim.